Aug 9, 2023 8:00 am EDT VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update
Jun 23, 2023 4:10 pm EDT VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters
Jun 5, 2023 4:10 pm EDT VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock
Jun 1, 2023 9:15 am EDT VolitionRx Limited Announces Pricing of $16.5 Million Underwritten Public Offering of Common Stock
May 31, 2023 4:01 pm EDT VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
May 11, 2023 7:00 am EDT Volition Study shows Nucleosome Concentrations are a useful tool for Canine Cancer Treatment Monitoring
May 10, 2023 4:10 pm EDT VolitionRx Limited Announces First Quarter 2023 Financial Results and Business Update
May 5, 2023 8:00 am EDT VolitionRx Limited Schedules First Quarter 2023 Earnings Conference Call and Business Update
Apr 26, 2023 7:30 am EDT VolitionRx Limited to Host Capital Markets Day at the NYSE on Thursday May 11.
Mar 15, 2023 4:10 pm EDT VolitionRx Limited Announces Full Fiscal Year 2022 Financial Results and Business Update
